164 related articles for article (PubMed ID: 2929629)
1. Transient hypertension after two phenylpropanolamine diet aids and the effects of caffeine: a placebo-controlled follow-up study.
Lake CR; Zaloga G; Bray J; Rosenberg D; Chernow B
Am J Med; 1989 Apr; 86(4):427-32. PubMed ID: 2929629
[TBL] [Abstract][Full Text] [Related]
2. A double dose of phenylpropanolamine causes transient hypertension.
Lake CR; Zaloga G; Clymer R; Quirk RM; Chernow B
Am J Med; 1988 Sep; 85(3):339-43. PubMed ID: 3414729
[TBL] [Abstract][Full Text] [Related]
3. A controlled clinical trial of the cardiovascular and psychological effects of phenylpropanolamine and caffeine.
Noble R
Drug Intell Clin Pharm; 1988 Apr; 22(4):296-9. PubMed ID: 3286173
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic doses of phenylpropanolamine increase supine systolic blood pressure.
Pentel PR; Aaron C; Paya C
Int J Obes; 1985; 9(2):115-9. PubMed ID: 4030197
[TBL] [Abstract][Full Text] [Related]
5. Phenylpropanolamine and caffeine use among diet center clients.
Lake CR; Rosenberg D; Quirk R
Int J Obes; 1990 Jul; 14(7):575-82. PubMed ID: 2228392
[TBL] [Abstract][Full Text] [Related]
6. Do pseudoephedrine or phenylpropanolamine improve maximum oxygen uptake and time to exhaustion?
Swain RA; Harsha DM; Baenziger J; Saywell RM
Clin J Sport Med; 1997 Jul; 7(3):168-73. PubMed ID: 9262882
[TBL] [Abstract][Full Text] [Related]
7. Adverse drug effects attributed to phenylpropanolamine: a review of 142 case reports.
Lake CR; Gallant S; Masson E; Miller P
Am J Med; 1990 Aug; 89(2):195-208. PubMed ID: 2200264
[TBL] [Abstract][Full Text] [Related]
8. Cerebral hemorrhage associated with phenylpropanolamine in combination with caffeine.
Mueller SM; Muller J; Asdell SM
Stroke; 1984; 15(1):119-23. PubMed ID: 6695415
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of phenylpropanolamine and associated effects on blood pressure in normotensive subjects: a pilot-study.
Dowse R; Scherzinger SS; Kanfer I
Int J Clin Pharmacol Ther Toxicol; 1990 May; 28(5):205-10. PubMed ID: 2194987
[TBL] [Abstract][Full Text] [Related]
10. Propranolol antagonism of phenylpropanolamine-induced hypertension.
Pentel PR; Asinger RW; Benowitz NL
Clin Pharmacol Ther; 1985 May; 37(5):488-94. PubMed ID: 3987172
[TBL] [Abstract][Full Text] [Related]
11. The effect of phenylpropanolamine on ambulatory blood pressure.
Goodman RP; Wright JT; Barlascini CO; McKenney JM; Lambert CM
Clin Pharmacol Ther; 1986 Aug; 40(2):144-7. PubMed ID: 3731678
[TBL] [Abstract][Full Text] [Related]
12. Hypertensive responses induced by phenylpropanolamine in anorectic and decongestant preparations.
Horowitz JD; Lang WJ; Howes LG; Fennessy MR; Christophidis N; Rand MJ; Louis WJ
Lancet; 1980 Jan; 1(8159):60-1. PubMed ID: 6153233
[TBL] [Abstract][Full Text] [Related]
13. Intracranial hemorrhages due to phenylpropanolamine.
Kikta DG; Devereaux MW; Chandar K
Stroke; 1985; 16(3):510-2. PubMed ID: 4002267
[TBL] [Abstract][Full Text] [Related]
14. The effects of phenylpropanolamine on human sympathetic nervous system function.
Lake CR; Chernow B; Zaloga G; Labow J; Quirk R; Hedges SM
Neuropsychopharmacology; 1988 May; 1(2):163-8. PubMed ID: 3251497
[TBL] [Abstract][Full Text] [Related]
15. The effect of multiple doses of phenylpropanolamine on the blood pressure of patients whose hypertension was controlled with beta blockers.
O'Connell MB; Gross CR
Pharmacotherapy; 1991; 11(5):376-81. PubMed ID: 1684039
[TBL] [Abstract][Full Text] [Related]
16. The acute effect of phenylpropanolamine and brompheniramine on blood pressure in controlled hypertension: a randomized double-blind crossover trial.
Petrulis AS; Imperiale TF; Speroff T
J Gen Intern Med; 1991; 6(6):503-6. PubMed ID: 1684991
[TBL] [Abstract][Full Text] [Related]
17. Effects of sustained-release oral phenylpropanolamine on the nasal mucosa of healthy subjects.
Graf P; Toll K; Palm J; Hallén H
Acta Otolaryngol; 1999; 119(7):837-42. PubMed ID: 10687944
[TBL] [Abstract][Full Text] [Related]
18. Severe hypertension after ingestion of an appetite suppressant (phenylpropanolamine) with indomethacin.
Lee KY; Beilin LJ; Vandongen R
Lancet; 1979 May; 1(8126):1110-1. PubMed ID: 86834
[TBL] [Abstract][Full Text] [Related]
19. Determinants of the pressor effect of phenylpropanolamine in healthy subjects.
Blackburn GL; Morgan JP; Lavin PT; Noble R; Funderburk FR; Istfan N
JAMA; 1989 Jun; 261(22):3267-72. PubMed ID: 2716162
[TBL] [Abstract][Full Text] [Related]
20. Dose-dependent response to phenylpropanolamine: inhibition of orthostasis.
Lake CR; Rosenberg DB; Gallant S; Zaloga G; Chernow B
J Clin Pharmacol; 1991 Jul; 31(7):624-35. PubMed ID: 1894758
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
